Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CSL | Sydney | Healthcare | Pharmaceuticals | A$131.26B | 31x | 1.54 | A$270.25 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.9% Upside | Upgrade to Pro+ | |
Ebos | Sydney | Healthcare | Pharmaceuticals | A$6.45B | 23.4x | 3.76 | A$33 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.5% Upside | Upgrade to Pro+ | |
Sigma Pharma | Sydney | Healthcare | Pharmaceuticals | A$4.17B | -1,320x | 12.36 | A$2.64 | -5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -28.1% Downside | Upgrade to Pro+ | |
Neuren Pharma | Sydney | Healthcare | Pharmaceuticals | A$1.75B | 15.2x | 0.13 | A$14.01 | 3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Botanix Pharma | Sydney | Healthcare | Pharmaceuticals | A$836.14M | -50.6x | 3.76 | A$0.46 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38.3% Upside | Upgrade to Pro+ | |
Clinuvel Pharmaceuticals | Sydney | Healthcare | Pharmaceuticals | A$584.88M | 16.4x | 0.92 | A$11.71 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Mayne Pharma | Sydney | Healthcare | Pharmaceuticals | A$368.86M | -2.1x | 0.01 | A$4.56 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.1% Upside | Upgrade to Pro+ | |
AFT Pharmaceuticals | Sydney | Healthcare | Pharmaceuticals | A$271.60M | 28.1x | -0.8 | A$2.59 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biome Australia | Sydney | Healthcare | Pharmaceuticals | A$117.23M | -85.9x | -1.49 | A$0.62 | 15.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Syntara | Sydney | Healthcare | Pharmaceuticals | A$112.12M | -4.6x | -0.99 | A$0.07 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Recce | Sydney | Healthcare | Pharmaceuticals | A$111.30M | -4.8x | 0.19 | A$0.49 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vita Life Sciences | Sydney | Healthcare | Pharmaceuticals | A$110.17M | 11.4x | 0.44 | A$1.97 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Neurizon Therapeutics | Sydney | Healthcare | Pharmaceuticals | A$59.03M | -5.7x | 0.96 | A$0.12 | -8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Radiopharm Theranostics | Sydney | Healthcare | Pharmaceuticals | A$56.50M | -0.2x | 0.14 | A$0.03 | 3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Inoviq | Sydney | Healthcare | Pharmaceuticals | A$52.42M | -6.6x | -0.29 | A$0.47 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Starpharma Holdings | Sydney | Healthcare | Pharmaceuticals | A$50.17M | -5.5x | -0.11 | A$0.12 | 4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vitura Health | Sydney | Healthcare | Pharmaceuticals | A$47.11M | 14.1x | -0.18 | A$0.08 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medical Developments | Sydney | Healthcare | Pharmaceuticals | A$45.63M | -0.9x | 0 | A$0.41 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Next Science | Sydney | Healthcare | Pharmaceuticals | A$42.36M | -2.7x | -0.07 | A$0.14 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Little Green Pharma | Sydney | Healthcare | Pharmaceuticals | A$31.80M | -4x | 0.02 | A$0.11 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oncosil Medical Ltd | Sydney | Healthcare | Pharmaceuticals | A$22.48M | -1x | -0.04 | A$0.005 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Immuron Ltd | Sydney | Healthcare | Pharmaceuticals | A$19.71M | -2.9x | 0.03 | A$0.09 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nyrada | Sydney | Healthcare | Pharmaceuticals | A$18.09M | -6.1x | -0.16 | A$0.08 | -5.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Althea | Sydney | Healthcare | Pharmaceuticals | A$17.27M | -0.4x | 0 | A$0.03 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Calmer Co International | Sydney | Healthcare | Pharmaceuticals | A$15.25M | -2x | -0.05 | A$0.006 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Firebrick Pharma | Sydney | Healthcare | Pharmaceuticals | A$12.82M | -10.1x | -0.13 | A$0.06 | 3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Anatara Lifesciences Ltd | Sydney | Healthcare | Pharmaceuticals | A$11.64M | -5.6x | -0.15 | A$0.06 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Argent BioPharma | Sydney | Healthcare | Pharmaceuticals | A$10.85M | -0.4x | -0.01 | A$0.20 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Acrux | Sydney | Healthcare | Pharmaceuticals | A$9.01M | -1.6x | 0 | A$0.03 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TrivarX | Sydney | Healthcare | Pharmaceuticals | A$7.90M | -4.3x | -0.07 | A$0.02 | 12.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |